Cargando…
Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer
INTRODUCTION: There is a critical need to develop clinical laboratory assays that provide risk assessment for men at elevated risk for prostate cancer, and once diagnosed, could further identify those men with clinically significant disease. METHODS: Recent advancements in analytical instrumentation...
Autores principales: | McDunn, Jonathan E., Stirdivant, Steven M., Ford, Lisa A., Wolfert, Robert L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975355/ https://www.ncbi.nlm.nih.gov/pubmed/27683485 |
Ejemplares similares
-
Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
por: Wittmann, Bryan M., et al.
Publicado: (2014) -
Metabolomic Laboratory-Developed Tests: Current Status and Perspectives
por: Lichtenberg, Steven, et al.
Publicado: (2021) -
Leukocyte phenotyping to stratify septic shock patients
por: McDunn, Jonathan E, et al.
Publicado: (2009) -
Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension
por: Hiltunen, Timo P., et al.
Publicado: (2017) -
Diagnosis of Parkinson’s Disease by A Metabolomics-Based Laboratory-Developed Test (LDT)
por: Lokhov, Petr G., et al.
Publicado: (2020)